Zobrazeno 1 - 10
of 316
pro vyhledávání: '"Rhonda M Cooper-Dehoff"'
Autor:
Catherine G Derington, Jordana B Cohen, April F Mohanty, Tom H Greene, James Cook, Jian Ying, Guo Wei, Jennifer S Herrick, Vanessa W Stevens, Barbara E Jones, Libo Wang, Alexander R Zheutlin, Andrew M South, Thomas C Hanff, Steven M Smith, Rhonda M Cooper-DeHoff, Jordan B King, G Caleb Alexander, Dan R Berlowitz, Faraz S Ahmad, M Jason Penrod, Rachel Hess, Molly B Conroy, James C Fang, Michael A Rubin, Srinivasan Beddhu, Alfred K Cheung, Weiming Xian, William S Weintraub, Adam P Bress
Publikováno v:
PLoS ONE, Vol 16, Iss 4, p e0248080 (2021)
BackgroundAngiotensin II receptor blockers (ARBs) and angiotensin-converting enzyme inhibitors (ACEIs) may positively or negatively impact outcomes in severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection. We investigated the associa
Externí odkaz:
https://doaj.org/article/9f95d8c5dcd04d9b8f8dc9e9a0d7a189
Autor:
Patrick N Cunningham, Zhiying Wang, Megan L Grove, Rhonda M Cooper-DeHoff, Amber L Beitelshees, Yan Gong, John G Gums, Julie A Johnson, Stephen T Turner, Eric Boerwinkle, Arlene B Chapman
Publikováno v:
PLoS ONE, Vol 14, Iss 9, p e0221957 (2019)
BackgroundHypertension (HTN) disproportionately affects African Americans (AAs), who respond better to thiazide diuretics than other antihypertensives. Variants of the APOL1 gene found in AAs are associated with a higher rate of kidney disease and pl
Externí odkaz:
https://doaj.org/article/b7b90da9426a414aaf85d890cebafa81
Autor:
Logan Dumitrescu, Marylyn D Ritchie, Joshua C Denny, Nihal M El Rouby, Caitrin W McDonough, Yuki Bradford, Andrea H Ramirez, Suzette J Bielinski, Melissa A Basford, High Seng Chai, Peggy Peissig, David Carrell, Jyotishman Pathak, Luke V Rasmussen, Xiaoming Wang, Jennifer A Pacheco, Abel N Kho, M Geoffrey Hayes, Martha Matsumoto, Maureen E Smith, Rongling Li, Rhonda M Cooper-DeHoff, Iftikhar J Kullo, Christopher G Chute, Rex L Chisholm, Gail P Jarvik, Eric B Larson, David Carey, Catherine A McCarty, Marc S Williams, Dan M Roden, Erwin Bottinger, Julie A Johnson, Mariza de Andrade, Dana C Crawford
Publikováno v:
PLoS ONE, Vol 12, Iss 2, p e0171745 (2017)
Resistant hypertension is defined as high blood pressure that remains above treatment goals in spite of the concurrent use of three antihypertensive agents from different classes. Despite the important health consequences of resistant hypertension, f
Externí odkaz:
https://doaj.org/article/b002153fafa945a8b48317afbc1af625
Autor:
Yuan Lu, Ellen C. Keeley, Eric Barrette, Rhonda M. Cooper-DeHoff, Sanket S. Dhruva, Jenny Gaffney, Ginger Gamble, Bonnie Handke, Chenxi Huang, Harlan M. Krumholz, Caitrin W. McDonough, Wade Schulz, Kathryn Shaw, Myra Smith, Jennifer Woodard, Patrick Young, Keondae Ervin, Joseph S. Ross
Publikováno v:
BMC Cardiovascular Disorders, Vol 24, Iss 1, Pp 1-17 (2024)
Abstract Background Improving hypertension control is a public health priority. However, consistent identification of uncontrolled hypertension using computable definitions in electronic health records (EHR) across health systems remains uncertain. M
Externí odkaz:
https://doaj.org/article/e304d9fa864d47d79b10019f10feec13
Autor:
Scott J Denardo, Yan Gong, Rhonda M Cooper-DeHoff, Csaba Farsang, Matyas Keltai, László Szirmai, Franz H Messerli, Anthony A Bavry, Eileen M Handberg, Giuseppe Mancia, Carl J Pepine
Publikováno v:
PLoS ONE, Vol 11, Iss 6, p e0157212 (2016)
[This corrects the article DOI: 10.1371/journal.pone.0122726.].
Externí odkaz:
https://doaj.org/article/23444140101e4bd2bca74ff2e4731bce
Autor:
Scott J Denardo, Yan Gong, Rhonda M Cooper-DeHoff, Csaba Farsang, Matyas Keltai, László Szirmai, Franz H Messerli, Anthony A Bavry, Eileen M Handberg, Giuseppe Mancia, Carl J Pepine
Publikováno v:
PLoS ONE, Vol 10, Iss 4, p e0122726 (2015)
Elevated nighttime blood pressure (BP) and heart rate (HR), increased BP and HR variability, and altered diurnal variations of BP and HR (nighttime dipping and morning surge) in patients with systemic hypertension are each associated with increased a
Externí odkaz:
https://doaj.org/article/254fec39511f480cbfc333de6ab68b58
Autor:
Emily J. Cicali, Elizabeth Eddy, Yan Gong, Amanda L. Elchynski, Kim Pena del Aguila, Tala Basha, Karen C. Daily, Lauren Dickson, Steven Fischer, Erin Hastings‐Monari, Dennie Jones Jr., Brian H. Ramnaraign, David L. DeRemer, Thomas J. George, Rhonda M. Cooper‐DeHoff
Publikováno v:
Clinical and Translational Science, Vol 17, Iss 7, Pp n/a-n/a (2024)
Abstract The University of Florida Health conducted a pragmatic implementation of a pharmacogenetics (PGx) panel‐based test to guide medications used for supportive care prescribed to patients undergoing chemotherapy. The implementation was in the
Externí odkaz:
https://doaj.org/article/6ba77f494cb54183b06d4c9b1083c926
Autor:
Caitrin W McDonough, Nancy K Gillis, Abdullah Alsultan, Shin-Wen Chang, Marina Kawaguchi-Suzuki, Jason E Lang, Mohamed Hossam A Shahin, Thomas W Buford, Nihal M El Rouby, Ana C C Sá, Taimour Y Langaee, John G Gums, Arlene B Chapman, Rhonda M Cooper-DeHoff, Stephen T Turner, Yan Gong, Julie A Johnson
Publikováno v:
PLoS ONE, Vol 8, Iss 10, p e76984 (2013)
We sought to identify novel pharmacogenomic markers for HDL-C response to atenolol in participants with mild to moderate hypertension. We genotyped 768 hypertensive participants from the Pharmacogenomic Evaluation of Antihypertensive Responses (PEAR)
Externí odkaz:
https://doaj.org/article/43b24bd0d8ac4ea89759ec6bfc82818f
Autor:
William R Wikoff, Reginald F Frye, Hongjie Zhu, Yan Gong, Stephen Boyle, Erik Churchill, Rhonda M Cooper-Dehoff, Amber L Beitelshees, Arlene B Chapman, Oliver Fiehn, Julie A Johnson, Rima Kaddurah-Daouk, Pharmacometabolomics Research Network
Publikováno v:
PLoS ONE, Vol 8, Iss 3, p e57639 (2013)
Antihypertensive drugs are among the most commonly prescribed drugs for chronic disease worldwide. The response to antihypertensive drugs varies substantially between individuals and important factors such as race that contribute to this heterogeneit
Externí odkaz:
https://doaj.org/article/d2b6bc8cefe145d49acf45c164a8158f
Autor:
Abdoreza Davoodi-Semiromi, Clive H Wasserfall, Chang Qing Xia, Rhonda M Cooper-DeHoff, Martin Wabitsch, Michael Clare-Salzler, Mark Atkinson
Publikováno v:
PLoS ONE, Vol 7, Iss 5, p e36079 (2012)
Recent studies in the NOD (non-obese diabetic) mouse model of type 1 diabetes (T1D) support the notion that tyrosine kinase inhibitors have the potential for modulating disease development. However, the therapeutic effects of AG490 on the development
Externí odkaz:
https://doaj.org/article/c80d468084604c89aa275bcd47a6c83e